Ventas (Ventas) Net Margin %

: -7.80% (As of Dec. 2023)

View and export this data going back to 1997. Start your Free Trial

Net margin is calculated as Net Income divided by its Revenue. Ventas's Net Income for the three months ended in Dec. 2023 was $-91 Mil. Ventas's Revenue for the three months ended in Dec. 2023 was $1,164 Mil. Therefore, Ventas's net margin for the quarter that ended in Dec. 2023 was -7.80%.

The historical rank and industry rank for Ventas's Net Margin % or its related term are showing as below:

VTR' s Net Margin % Range Over the Past 10 Years
Min: -1.15 Med: 11.38 Max: 37.95
Current: -0.91

VTR's Net Margin % is ranked worse than
73.27% of 797 companies
in the REITs industry
Industry Median: 32.78 vs VTR: -0.91

Ventas Net Margin % Historical Data

The historical data trend for Ventas's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ventas Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Margin %

11.18

11.57

1.28

-1.15

-0.91

Ventas Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Net Margin %																-4.28	1.63	9.35	-6.19	-7.80

Competitive Comparison

For the REIT - Healthcare Facilities subindustry, Ventas's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ventas Net Margin % Distribution

For the REITs industry and Real Estate sector, Ventas's Net Margin % distribution charts can be found below:

* The bar in red indicates where Ventas's Net Margin % falls into.

Ventas Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Ventas's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-40.973	/	4497.827
	=	-0.91 %

Ventas's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-90.819	/	1164.392
	=	-7.80 %

Ventas (NYSE:VTR) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Ventas Net Margin % Related Terms

Thank you for viewing the detailed overview of Ventas's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Ventas (Ventas) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Real Estate » REITs » Ventas Inc (NYSE:VTR) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

VEN:Germany V1TA34:Brazil

Address

353 North Clark Street, Suite 3300, Chicago, IL, USA, 60654

Website

https://www.ventasreit.com

Ventas owns a diversified healthcare portfolio of nearly 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes over 40 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 3% of net operating income.

Executives

Walter C Rakowich	director	14100 E 35TH PL, AURORA CO 80011
Debra A Cafaro	director, officer: Chairman, President and CEO	353 N. CLARK STREET, SUITE 3300, CHICAGO IL 60654
Sumit Roy	director	600 LA TERRAZA BOULEVARD, ESCONDIDO CA 92025
Michael J Embler	director	C/O NMI HOLDINGS, INC., 2100 POWELL STREET, EMERYVILLE CA 94608
Robert D. Reed	director	47 DONALD DRIVE, ORINDA CA 94563
James D Shelton	director	3901 TURTLE CREEK BLVD. #12, DALLAS TX 75219
Richard I Gilchrist	director	5950 SHERRY LANE, SUITE 700, DALLAS TX 75225
Robert F Probst	officer: EVP, CFO and Acting CAO	353 N. CLARK STREET, SUITE 3300, CHICAGO IL 60654
Gregory R Liebbe	officer: SVP, Chief Accounting Officer	500 N. HURSTBOURNE PARKWAY, SUITE 200, LOUISVILLE KY 40222
Maurice S Smith	director	353 N. CLARK STREET, SUITE 3300, CHICAGO IL 60654
Marguerite M Nader	director	2S601 AVENUE LA TOURS, OAK BROOK IL 60523
Carey S. Roberts	officer: EVP and GC	C/O VENTAS, INC., 353 N. CLARK STREET, SUITE 3300, CHICAGO IL 60654
James Justin Hutchens	officer: EVP Sr Housing North America	C/O VENTAS, INC., 353 N. CLARK STREET, SUITE 3300, CHICAGO IL 60654
John D. Cobb	officer: SVP & Chief Investment Officer	353 N. CLARK STREET, SUITE 3300, CHICAGO IL 60654
Sean P. Nolan	director	C/O INTERMUNE, INC., 3280 BAYSHORE BLVD., BRISBANE CA 94005